15820051

Son WY

2005

Pregnancy resulting from transfer of repeat vitrified blastocysts produced by in-vitro matured oocytes in patient with polycystic ovary syndrome.

15820804

Oksjoki S

2005

Molecular profiling of polycystic ovaries for markers of cell invasion and matrix turnover.

15820805

Costello MF

2005

Power Doppler ultrasound assessment of ovarian perifollicular blood flow in women with polycystic ovaries and normal ovaries during in vitro fertilization treatment.

15823827

Heald A

2005

Screening for insulin resistance in women with polycystic ovarian syndrome.

15824974

Ciampani M

2005

Sex hormones in patients with epilepsy-hormonal changes in epileptic men and women taking antiepileptics.

15827095

Davison SL

2005

Androgen levels in adult females: changes with age, menopause, and oophorectomy.

15827099

Gambineri A

2005

Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome.

15827102

Wild RA

2005

Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome.

15827106

San Mill?n JL

2005

A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome.

15828237

Ohnaka K

2005

[Polycystic ovary syndrome].

15831308

Allon MA

2005

Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion.

15831514

van Wely M

2005

Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome.

15832489

Gungor N

2002

Pathophysiology of type 2 diabetes mellitus in children and adolescents: treatment implications.

15833266

Magoffin DA

2005

Ovarian theca cell.

15833775

Spaczynski RZ

2005

Insulin and insulin-like growth factors inhibit and luteinizing hormone augments ovarian theca-interstitial cell apoptosis.

15838095

New MI

2004

An update of congenital adrenal hyperplasia.

15840293

Qiu HY

2005

[Tyrosine phosphorylation and protein expression of insulin receptor substrate-2 in the adipose tissue from patients with polycystic ovary syndrome].

15840294

Wang ZC

2005

[Expression of insulin receptor substrate 1 and phosphorylation of tyrosine in adipose tissue of polycystic ovary syndrome].

15840746

Palomba S

2005

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome.

15841928

Gardella C

2005

Prevalence of hysterectomy and associated factors in women Veterans Affairs patients.

15845598

Ng EH

2005

Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome.

15846568

Pfeifer SM

2005

Polycystic ovary syndrome in adolescent girls.

15850263

Budgen V

2005

Improving the detection of polycystic ovary syndrome.

15850535

Wikiera B

2005

[Adrenal function in girls with hirsutism].

15853827

Hahn S

2005

The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.

15855259

Codner E

2005

Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide.

15860277

Tsutsumi O

2005

Assessment of human contamination of estrogenic endocrine-disrupting chemicals and their risk for human reproduction.

15862282

Lewandowski KC

2005

Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.

15863587

Maruyama T

2005

Follicle stimulating hormone-secreting pituitary microadenoma with fluctuating levels of ovarian hyperstimulation.

15864003

Zukauskaite S

2005

Serum hormone levels and anthropometric characteristics in girls with hyperandrogenism.

15865813

Al-Inany H

2004

Polycystic ovary syndrome.

15866567

Azziz R

2005

Diagnostic criteria for polycystic ovary syndrome: a reappraisal.

15866584

DeUgarte CM

2005

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.

15866585

Cha KY

2005

Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer.

15866586

Gra?a-Barcia M

2005

Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.

15866608

Walch K

2005

A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the presence of polycystic ovary syndrome in Caucasian women.

15866611

Vanky E

2005

Placental passage of metformin in women with polycystic ovary syndrome.

15867020

Lipton RB

2005

Obesity at the onset of diabetes in an ethnically diverse population of children: what does it mean for epidemiologists and clinicians?

15870132

Meyer C

2005

Vascular dysfunction and metabolic parameters in polycystic ovary syndrome.

15870557

Erel CT

2005

Is laparoscopy necessary before assisted reproductive technology?

15878899

Checa MA

2005

Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.

15878924

Yang SH

2005

Correlation between in vitro maturation and expression of LH receptor in cumulus cells of the oocytes collected from PCOS patients in HCG-primed IVM cycles.

15878925

Homburg R

2005

Clomiphene citrate--end of an era? A mini-review.

15879361

Diamanti-Kandarakis E

2005

Metformin administration improves endothelial function in women with polycystic ovary syndrome.

15879463

Xita N

2005

Association of SHBG gene polymorphism with menarche.

15884693

van den Br?le F

2005

[Image of the month. Diagnosis of micropolycystic ovary by transvaginal ultrasonography].

15885201

Froment P

2005

[A role of PPARgamma in reproduction?].

15886247

Harborne LR

2005

Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.

15886251

Munir I

2005

Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome.

15888157

Clayton WJ

2005

A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome.

15889426

Gerendai I

2005

Occasional transsynaptic viral labeling in the central nervous system from the polycystic ovary induced by estradiol valerate.

15890734

Yilmaz M

2005

Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.

15890737

Panidis D

2005

Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.

15893251

Vgontzas AN

2005

Sleep apnea is a manifestation of the metabolic syndrome.

15898821

van Wely M

2005

Urofollitropin and ovulation induction.

15898962

Rasgon NL

2005

Reproductive function and risk for PCOS in women treated for bipolar disorder.

15899949

Sam S

2005

Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome.

15905296

Ib??ez L

2005

High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.

15910403

Brock B

2005

Is metformin therapy for polycystic ovary syndrome safe during pregnancy?

15911461

Myers ER

2005

Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial.

15914525

Wickenheisser JK

2005

Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome.

15915567

American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee.

2005

American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome.

15919773

Bjercke S

2005

IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.

15919774

Vural B

2005

Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome.

15919811

Young J

2005

Type A insulin resistance syndrome revealing a novel lamin A mutation.

15921170

Verrotti A

2005

Endocrine and metabolic changes in epileptic patients receiving valproic acid.

15921180

Guttmann-Bauman I

2005

Approach to adolescent polycystic ovary syndrome (PCOS) in the pediatric endocrine community in the U.S.A.

15921686

Hwu YM

2005

Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome.

15925014

Caballero AE

2005

Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation.

15926113

Haap M

2005

Genetic determinants of insulin action in polycystic ovary syndrome.

15931331

Sheehan MT

2004

Polycystic ovarian syndrome: diagnosis and management.

15932911

Doi SA

2005

Irregular cycles and steroid hormones in polycystic ovary syndrome.

15932917

Onalan G

2005

Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.

15935829

Carmassi F

2005

Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.

15937580

Al-Fozan H

2005

Insulin responses to the oral glucose tolerance test in women of different ethnicity with polycystic ovary syndrome.

15938775

Chen ZJ

2005

[Treatment of polycystic ovarian syndrome with anovulatory infertility by ultrasound-guided immature follicle aspiration].

15938783

Jin L

2005

[Polymorphism in insulin receptor gene exon 17 in women with polycystic ovary syndrome].

15941472

Manni L

2005

Effect of electro-acupuncture on ovarian expression of alpha (1)- and beta (2)-adrenoceptors, and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries.

15941616

La Marca A

2005

Metformin treatment of PCOS during adolescence and the reproductive period.

15941725

Abbott DH

2005

Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

15942248

Vrb?kov? J

2005

Determinants of circulating adiponectin in women with polycystic ovary syndrome.

15943823

Kumar A

2005

Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).

15944216

Azziz R

2005

Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.

15949215

Papanikolaou EG

2005

Immature oocyte in-vitro maturation: clinical aspects.

15949216

Mikkelsen AL

2005

Strategies in human in-vitro maturation and their clinical outcome.

15950640

Ardawi MS

2005

Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.

15950641

Chang WY

2005

Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups.

15950642

J??skel?inen J

2005

Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome.

15950665

Premoli AC

2005

Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome.

15954867

Tummon I

2005

Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*.

15958399

Palomba S

2005

A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.

15963037

Saad R

2005

Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates.

15963207

Soran A

2005

The prevalence of benign breast disease in women with polycystic ovary syndrome: a review of a 12-year follow-up.

15966558

Pelusi C

2003

Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications.

15967090

Pack A

2005

Effects of Treatment on Endocrine Function in Patients with Epilepsy.

15969998

Fratantonio E

2005

Genetics of polycystic ovarian syndrome.

15970010

Caglar GS

2005

Recombinant LH in ovarian stimulation.

15970011

Kumanov P

2005

Significance of inhibin in reproductive pathophysiology and current clinical applications.

15976539

Farquhar CM

2005

An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate-resistant polycystic ovarian syndrome.

15976547

Seif MW

2005

Managing disorders of ovulation: a model for evidence-based practice.